Innova Captab Limited (NSE:INNOVACAP)

Market Cap	52.15B
Revenue (ttm)	13.01B
Net Income (ttm)	1.30B
Shares Out	57.22M
EPS (ttm)	22.68
PE Ratio	40.18
Forward PE	27.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,486
Average Volume	42,509
Open	912.00
Previous Close	911.35
Day's Range	912.00 - 925.00
52-Week Range	648.00 - 1,260.00
Beta	n/a
RSI	54.28
Earnings Date	Aug 5, 2025

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinoly...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 1,600
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INNOVACAP

Financial Performance

In 2024, Innova Captab's revenue was 12.44 billion, an increase of 15.02% compared to the previous year's 10.81 billion. Earnings were 1.28 billion, an increase of 35.95%.